Gonadoblastoma overview: Difference between revisions

Jump to navigation Jump to search
(Undo revision 1714037 by Jose Loyola (talk))
Tag: Undo
 
(18 intermediate revisions by 4 users not shown)
Line 3: Line 3:
{{CMG}}; {{AE}} {{Sahar}}
{{CMG}}; {{AE}} {{Sahar}}
==Overview==
==Overview==
Gonadoblastoma is a [[benign tumor]] that almost exclusively involves individuals suspected of [[Intersexuality|intersex disorders]]. This [[tumor]] comprised of underdeveloped [[germ cells]] and sex-cord stromal cells which defines the term gonadoblastoma.


==Historical Perspective==
==Historical Perspective==
Gonadoblastoma was first discovered by Dr. Scully in 1953. The association between GBY gene (GonadoBlastoma on the Y chromosome) and gonadoblastoma was made in 1986. In 1995, Tsuchiya found that the GBY gene located near the [[centromere]] of [[Y chromosome]] and contains multiple [[gene]]<nowiki/>s including Testis-specific protein Y-encoded (TSPY) gene.
Gonadoblastoma was first discovered by Dr. Scully in 1953. The association between GBY [[gene]] (GonadoBlastoma on the Y chromosome) and gonadoblastoma was made in 1986. In 1995, Tsuchiya found that the GBY [[gene]] located near the [[centromere]] of [[Y chromosome]] and contains multiple [[gene]]<nowiki/>s including Testis-specific protein Y-encoded (TSPY) gene.


==Classification==
==Classification==
Line 14: Line 15:


==Causes==
==Causes==
There are no established causes for gonadoblastoma. However, there are certain risk factors that predispose to increased risk of gonadoblastoma.
There are no established [[causes]] for gonadoblastoma. However, there are certain [[risk factors]] that predispose to increased risk of gonadoblastoma.


==Differentiating Xyz from Other Diseases==
==Differentiating Gonadoblastoma from Other Diseases==
Gonadoblastoma must be differentiated from other [[diseases]] that cause [[virilization]], and [[primary amenorrhea]] and also must be differentiated [[Pathological|pathologically]] from [[dysgerminoma]], [[Sex-cord]] stromal [[tumors]], and [[Sertoli-cell]] [[nodules]].
Gonadoblastoma must be differentiated from other [[diseases]] that cause [[virilization]], and [[primary amenorrhea]] and also must be differentiated [[Pathological|pathologically]] from [[dysgerminoma]], [[Sex-cord]] stromal [[tumors]], and [[Sertoli-cell]] [[nodules]].


Line 43: Line 44:
===Laboratory Findings===
===Laboratory Findings===
Gonadoblastoma has no [[specific]] [[laboratory]] findings.
Gonadoblastoma has no [[specific]] [[laboratory]] findings.
===Electrocardiogram===
There are no [[ECG]] findings associated with gonadoblastoma.


===X-ray===
===X-ray===
An [[Abdominal|abdominal/]][[pelvic]] [[X-ray]] may be helpful in the [[diagnosis]] of [[calcification]] in the [[gonads]] associated with gonadoblastoma.


===Ultrasound===
===Ultrasound===
There are no [[ultrasound]] findings associated with gonadoblastoma. However, an [[ultrasound]]  may be helpful in the evaluation of a [[mass]] in the [[gonads]] and the exclusion of associated [[conditions]].


===CT scan===
===CT scan===
There are no characteristic [[CT scan]] or [[MRI]] findings associated with gonadoblastoma. However, an [[imaging]] study may be helpful in the [[diagnosis]] of associated [[conditions]] of this [[disorder]], which include [[gonadal dysgenesis]], [[Turner syndrome]], and etc.


===MRI===
===MRI===
[[MRI]] is usually not indicated for the [[diagnosis]] of gonadoblastoma.


===Other Imaging Findings===
===Other Imaging Findings===
There are no other [[imaging]] findings associated with gonadoblastoma.


===Other Diagnostic Studies===
===Other Diagnostic Studies===
There are no other [[Diagnosis|diagnostic studies]] associated with gonadoblastoma.


==Treatment==
==Treatment==
===Medical Therapy===
===Medical Therapy===
 
The mainstay of treatment for gonadoblastoma is [[surgery]]. [[Hormonal replacement therapy]] may be considered depending on the underlying [[condition]].


===Surgery===
===Surgery===
[[Surgery]] is the mainstay of treatment for gonadoblastoma. It should be removed as soon as it is diagnosed.


===Primary Prevention===
===Primary Prevention===
There are no established measures for the [[primary prevention]] of gonadoblastoma.


===Secondary Prevention===
===Secondary Prevention===
There are no established measures for the [[secondary prevention]] of gonadoblastoma.


==References==
==References==
Line 71: Line 85:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Medicine]]
[[Category:Medicine]]
[[Category:Primary care]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Gynecology]]
[[Category:Gynecology]]
[[Category:Up-To-Date]]
[[Category:Up-To-Date]]

Latest revision as of 22:49, 16 September 2021

Gonadoblastoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gonadoblastoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gonadoblastoma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gonadoblastoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gonadoblastoma overview

CDC on Gonadoblastoma overview

Gonadoblastoma overview in the news

Blogs on Gonadoblastoma overview

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Gonadoblastoma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Overview

Gonadoblastoma is a benign tumor that almost exclusively involves individuals suspected of intersex disorders. This tumor comprised of underdeveloped germ cells and sex-cord stromal cells which defines the term gonadoblastoma.

Historical Perspective

Gonadoblastoma was first discovered by Dr. Scully in 1953. The association between GBY gene (GonadoBlastoma on the Y chromosome) and gonadoblastoma was made in 1986. In 1995, Tsuchiya found that the GBY gene located near the centromere of Y chromosome and contains multiple genes including Testis-specific protein Y-encoded (TSPY) gene.

Classification

Gonadoblastoma may be classified according to pathological appearance into three sub-types including classical, dissecting, and burnt-out.

Pathophysiology

The exact pathogenesis of gonadoblastoma is not fully understood. Gonadal development starts at 5 weeks of gestation and continues according to sex chromosomes. Any defects in this complicated process leads to defective gonadal development and gonadal dysgenesis and subsequently, it may be converted to gonadoblastoma in 20% to 30% of the cases.

Causes

There are no established causes for gonadoblastoma. However, there are certain risk factors that predispose to increased risk of gonadoblastoma.

Differentiating Gonadoblastoma from Other Diseases

Gonadoblastoma must be differentiated from other diseases that cause virilization, and primary amenorrhea and also must be differentiated pathologically from dysgerminoma, Sex-cord stromal tumors, and Sertoli-cell nodules.

Epidemiology and Demographics

The prevalence of gonadoblastoma depends on the chromosomal content, presence or absence of mosaicism, gonadal histology, and age of the patient and varies between 15,000 to 30,000 per 100,000 individuals worldwide. The incidence of gonadoblastoma varies according to the presence or absence of Y chromosomal content and age of the individual. Patients with Turner syndrome who have Y chromosomal content either completely or partially may develop gonadoblastoma with an incidence as high as 43,000 per 100,000 individuals worldwide. The incidence of gonadoblastoma among phenotypical females with XY gonadal abnormalities have been observed to be 40,000 per 100,000 individuals worldwide. Gonadoblastoma may be found at any age, but commonly presents before the age of 15 years. Since, it usually affects individuals with gonadal dysgenesis, there is no genotype-phenotype correlation. Phenotypically, it tends to affect female individuals to a greater extent.

Risk Factors

The most potent risk factor in the development of gonadoblastoma is gonadal dysgenesis. The risk also increases with age.

Screening

There is insufficient evidence to recommend routine screening for gonadoblastoma. However, patients with XY gonadal abnormalities should be followed using sonography starting at age 2, every six months, until the gonads are removed.

Natural History, Complications, and Prognosis

Gonadoblastoma per se is a benign tumor, however, it has the capacity to convert to dysgerminoma or other more malignant germ cell tumors and produce steroids with resultant virilization. Prognosis is generally excellent after removing the tumor.

Diagnosis

Diagnostic Study of Choice

There are no established criteria for the diagnosis of gonadoblastoma. It is often found during a workup for ambiguous genitalia in infancy or sexual developmental disorder in puberty. Chromosomal analysis plays the most beneficial role in the diagnosis of conditions associated with gonadoblastoma. However, sometimes the Y chromosome materials are present in molecular level and cannot be diagnosed karyotypically. In theses individuals, molecular analysis of chromosomes using polymerase chain reaction (PCR) and/or fluorescence in situ hybridization (FISH) may be helpful.

History and Symptoms

Patients with gonadoblastoma present either during infancy with ambiguous genitalia or later with sexual developmental complaints. The hallmark of gonadoblastoma is gonadal developmental disorders.

Physical Examination

Gonadoblastoma has no characteristic physical feature, however, any clue to the existence of an intersex disorder must raise the concern for diagnosing the coexisting gonadoblastoma.

Laboratory Findings

Gonadoblastoma has no specific laboratory findings.

Electrocardiogram

There are no ECG findings associated with gonadoblastoma.

X-ray

An abdominal/pelvic X-ray may be helpful in the diagnosis of calcification in the gonads associated with gonadoblastoma.

Ultrasound

There are no ultrasound findings associated with gonadoblastoma. However, an ultrasound may be helpful in the evaluation of a mass in the gonads and the exclusion of associated conditions.

CT scan

There are no characteristic CT scan or MRI findings associated with gonadoblastoma. However, an imaging study may be helpful in the diagnosis of associated conditions of this disorder, which include gonadal dysgenesis, Turner syndrome, and etc.

MRI

MRI is usually not indicated for the diagnosis of gonadoblastoma.

Other Imaging Findings

There are no other imaging findings associated with gonadoblastoma.

Other Diagnostic Studies

There are no other diagnostic studies associated with gonadoblastoma.

Treatment

Medical Therapy

The mainstay of treatment for gonadoblastoma is surgery. Hormonal replacement therapy may be considered depending on the underlying condition.

Surgery

Surgery is the mainstay of treatment for gonadoblastoma. It should be removed as soon as it is diagnosed.

Primary Prevention

There are no established measures for the primary prevention of gonadoblastoma.

Secondary Prevention

There are no established measures for the secondary prevention of gonadoblastoma.

References


Template:WikiDoc Sources